stockrowLabcorp Holdings Inc.
LH Healthcare Diagnostics & Research
Labcorp Holdings Inc.’s revenue for fiscal 2025 (year ended December 2025) was $14.0 billion, up 7.25% from fiscal 2024.
- Revenue
- +6.92%
- EPS
- +3.18%
- Free cash flow
- +44.7%
- Total debt
- +3.21%
Quarter to September 2026, against a year earlier
Follow LH
Alert me
Labcorp Holdings Inc. (LH) Net income
Labcorp Holdings Inc.'s net income for fiscal 2025 was $877.7M, up 17.5% from $747.1M in fiscal 2024. Over the twelve months to 30 September 2026 it was $1.0B. Over the past ten years it has ranged from $419.2M (fiscal 2023) to $2.4B (fiscal 2021); the current reading is higher than 55% of that period. Labcorp Holdings Inc. ranks 7th of 49 Diagnostics & Research companies by net income.
Net income, annual
Embed this chart
Annual newest first
| Period | Net income | Change |
|---|---|---|
| FY2025 | $877.7M | 17.48% |
| FY2024 | $747.1M | 78.22% |
| FY2023 | $419.2M | (67.27%) |
| FY2022 | $1.3B | (46.18%) |
| FY2021 | $2.4B | 52.83% |
| FY2020 | $1.6B | 88.75% |
| FY2019 | $824.9M | (6.67%) |
| FY2018 | $883.9M | (28.31%) |
| FY2017 | $1.2B | 72.94% |
| FY2016 | $712.9M | 62.50% |
Quarterly newest first
| Period | Net income | Change |
|---|---|---|
| Sep 2026 | $263.1M | (12.04%) |
| Jun 2026 | $299.1M | 7.59% |
| Mar 2026 | $278.0M | 68.59% |
| Dec 2025 | $164.9M | (36.94%) |
| 43 more quarters | Free account |
Against its own ten years
Net income against peers
| Company | Net income |
|---|---|
| A Agilent Technologies, Inc. compare | $1.4B |
| IQV IQVIA Holdings Inc. compare | $1.4B |
| DGX Quest Diagnostics Incorporated compare | $1.2B |
| LH Labcorp Holdings Inc. | $1.0B |
| MTD Mettler-Toledo International, Inc. compare | $905.6M |
| ILMN Illumina, Inc. compare | $895.0M |
| MEDP Medpace Holdings, Inc. compare | $517.8M |
| WAT Waters Corporation compare | $98.2M |
| GH Guardant Health, Inc. compare | −$485.1M |
What Net income is
Net Income tells an investor how much profit a company kept in a period after every cost, interest charge and tax.
Reported line item
More on LH
- Revenue
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement